NEW YORK, Oct. 7 /PRNewswire/ — Reportlinker.com announces that
a new market research report is available in its catalogue:
Co-promotion and Co-marketing Agreements in Pharma, Biotech and
Diagnostics, 4th edition
http://www.reportlinker.com/p0177971/Co-promotion-and-Co-marketing-Agreements-in-Pharma-Biotech-and-Diagnostics-4th-edition.html
DescriptionThe report provides a detailed understand and
analysis of how and why companies enter co-promotion and
co-marketing deals. The majority of deals are multicomponent
whereby the licensor retains either a right or option to
co-promote/market the resultant product of the research
collaboration. There are also numerous pure co-promotion/marketing
deals whereby the products originator takes on a
co-promotion/marketing partner in order to maximize a products
presence in the marketplace.
Understanding the flexibility of a prospective partner’s
negotiated deals terms provides critical insight into the
negotiation process in terms of what you can expect to achieve
during the negotiation of terms. Whilst many smaller companies will
be seeking details of the payments clauses, the devil is in the
detail in terms of how payments are triggered – contract documents
provide this insight where press releases and databases do
not.
This report contains over 700 links to online copies of
actual co-promotion and co-marketing contract documents as
submitted to the Securities Exchange Commission by biopharma
companies and their partners.
Contract documents provide the answers to numerous questions
about a prospective partner’s flexibility on a wide
‘/>”/>
SOURCE
